Microvesicles as Cell-Cell Messengers in Cardiovascular Diseases

被引:337
|
作者
Loyer, Xavier
Vion, Anne-Clemence
Tedgui, Alain
Boulanger, Chantal M. [1 ]
机构
[1] Paris Cardiovasc Res Ctr PARCC, INSERM, U970, F-75015 Paris, France
关键词
angiogenesis effect; atherosclerosis; cell-derived microparticles; exosomes; microRNA; CIRCULATING ENDOTHELIAL MICROPARTICLES; HUMAN ATHEROSCLEROTIC PLAQUES; CORONARY-ARTERY-DISEASE; LEUKOCYTE-DERIVED MICROPARTICLES; ACUTE MYOCARDIAL-INFARCTION; PLATELET-ACTIVATING-FACTOR; HORIZONTAL TRANSFER; INDUCE ANGIOGENESIS; APOPTOTIC BODIES; PROGENITOR CELLS;
D O I
10.1161/CIRCRESAHA.113.300858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell-cell communication has proven to be even more complex than previously thought since the discovery that extracellular vesicles serve as containers of biological information on various pathophysiological settings. Extracellular vesicles are classified into exosomes, microvesicles/microparticles, or apoptotic bodies, originating from different subcellular compartments. The cellular machinery controlling their formation and composition, as well as the mechanisms regulating their extracellular release, remain unfortunately much unknown. Extracellular vesicles have been found in plasma, urine, saliva, and inflammatory tissues. Their biomarker potential has raised significant interest in the cardiovascular field because the vesicle composition and microRNA content are specific signatures of cellular activation and injury. More than simply cell dust, extracellular vesicles are capable of transferring biological information to neighboring cells and play an active role in inflammatory diseases, including atherosclerosis and angiogenesis. The molecular interactions regulating these effects involve specific receptor activation, proteolytic enzymes, reactive oxygen species, or delivery of genetic information to target cells. Unraveling their mechanisms of action will likely open new therapeutic avenues.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 50 条
  • [31] Stem cell therapy in cardiovascular diseases
    Tse, Hung-Fat
    CELL RESEARCH, 2008, 18 (Suppl 1) : S12 - S12
  • [32] T cell senescence and cardiovascular diseases
    Hee Tae Yu
    Sungha Park
    Eui-Cheol Shin
    Won-Woo Lee
    Clinical and Experimental Medicine, 2016, 16 : 257 - 263
  • [33] Stem cell therapy in cardiovascular diseases
    Hung-Fat Tse
    Cell Research, 2008, 18 : S12 - S12
  • [34] Marrow cell therapies for cardiovascular diseases
    Cogle, Christopher R.
    Madlambayan, Gerard J.
    Hubsher, Grant
    Beckman, Chris
    Speisman, Rachel
    Tran-Son-Tay, Roger
    Pepine, Carl J.
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (06) : 687 - 694
  • [35] T cell senescence and cardiovascular diseases
    Yu, Hee Tae
    Park, Sungha
    Shin, Eui-Cheol
    Lee, Won-Woo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (03) : 257 - 263
  • [36] Human Cell Modeling for Cardiovascular Diseases
    Lippi, Melania
    Stadiotti, Ilaria
    Pompilio, Giulio
    Sommariva, Elena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 27
  • [38] DLITE Uses Cell-Cell Interface Movement to Better Infer Cell-Cell Tensions
    Vasan, Ritvik
    Maleckar, Mary M.
    Williams, C. David
    Rangamani, Padmini
    BIOPHYSICAL JOURNAL, 2019, 117 (09) : 1714 - 1727
  • [39] Engineering cell-cell signaling
    Blagovic, Katarina
    Gong, Emily S.
    Milano, Daniel F.
    Natividad, Robert J.
    Asthagiri, Anand R.
    CURRENT OPINION IN BIOTECHNOLOGY, 2013, 24 (05) : 940 - 947
  • [40] CELL-CELL INTERACTIONS IN THE TESTIS
    SKINNER, MK
    ENDOCRINE REVIEWS, 1991, 12 (01) : 45 - 77